Oxaprozin Market
1 Study Coverage
1.1 Oxaprozin Product Introduction
1.2 Market by Type
1.2.1 Global Oxaprozin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Oxaprozin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Rheumatoid Arthritis
1.3.3 Chronic Infectious Arthritis
1.3.4 Osteoarthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Neck Shoulder Wrist Syndrome
1.3.7 Periarthritis Of Shoulder
1.3.8 Gout
1.3.9 Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
1.3.10 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oxaprozin Sales Estimates and Forecasts 2017-2028
2.2 Global Oxaprozin Revenue Estimates and Forecasts 2017-2028
2.3 Global Oxaprozin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oxaprozin Sales by Region
2.4.1 Global Oxaprozin Sales by Region (2017-2022)
2.4.2 Global Sales Oxaprozin by Region (2023-2028)
2.5 Global Oxaprozin Revenue by Region
2.5.1 Global Oxaprozin Revenue by Region (2017-2022)
2.5.2 Global Oxaprozin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oxaprozin Sales by Manufacturers
3.1.1 Global Top Oxaprozin Manufacturers by Sales (2017-2022)
3.1.2 Global Oxaprozin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oxaprozin in 2021
3.2 Global Oxaprozin Revenue by Manufacturers
3.2.1 Global Oxaprozin Revenue by Manufacturers (2017-2022)
3.2.2 Global Oxaprozin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oxaprozin Revenue in 2021
3.3 Global Oxaprozin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oxaprozin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oxaprozin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oxaprozin Sales by Type
4.1.1 Global Oxaprozin Historical Sales by Type (2017-2022)
4.1.2 Global Oxaprozin Forecasted Sales by Type (2023-2028)
4.1.3 Global Oxaprozin Sales Market Share by Type (2017-2028)
4.2 Global Oxaprozin Revenue by Type
4.2.1 Global Oxaprozin Historical Revenue by Type (2017-2022)
4.2.2 Global Oxaprozin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oxaprozin Revenue Market Share by Type (2017-2028)
4.3 Global Oxaprozin Price by Type
4.3.1 Global Oxaprozin Price by Type (2017-2022)
4.3.2 Global Oxaprozin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oxaprozin Sales by Application
5.1.1 Global Oxaprozin Historical Sales by Application (2017-2022)
5.1.2 Global Oxaprozin Forecasted Sales by Application (2023-2028)
5.1.3 Global Oxaprozin Sales Market Share by Application (2017-2028)
5.2 Global Oxaprozin Revenue by Application
5.2.1 Global Oxaprozin Historical Revenue by Application (2017-2022)
5.2.2 Global Oxaprozin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oxaprozin Revenue Market Share by Application (2017-2028)
5.3 Global Oxaprozin Price by Application
5.3.1 Global Oxaprozin Price by Application (2017-2022)
5.3.2 Global Oxaprozin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oxaprozin Market Size by Type
6.1.1 North America Oxaprozin Sales by Type (2017-2028)
6.1.2 North America Oxaprozin Revenue by Type (2017-2028)
6.2 North America Oxaprozin Market Size by Application
6.2.1 North America Oxaprozin Sales by Application (2017-2028)
6.2.2 North America Oxaprozin Revenue by Application (2017-2028)
6.3 North America Oxaprozin Market Size by Country
6.3.1 North America Oxaprozin Sales by Country (2017-2028)
6.3.2 North America Oxaprozin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Oxaprozin Market Size by Type
7.1.1 Europe Oxaprozin Sales by Type (2017-2028)
7.1.2 Europe Oxaprozin Revenue by Type (2017-2028)
7.2 Europe Oxaprozin Market Size by Application
7.2.1 Europe Oxaprozin Sales by Application (2017-2028)
7.2.2 Europe Oxaprozin Revenue by Application (2017-2028)
7.3 Europe Oxaprozin Market Size by Country
7.3.1 Europe Oxaprozin Sales by Country (2017-2028)
7.3.2 Europe Oxaprozin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oxaprozin Market Size by Type
8.1.1 Asia Pacific Oxaprozin Sales by Type (2017-2028)
8.1.2 Asia Pacific Oxaprozin Revenue by Type (2017-2028)
8.2 Asia Pacific Oxaprozin Market Size by Application
8.2.1 Asia Pacific Oxaprozin Sales by Application (2017-2028)
8.2.2 Asia Pacific Oxaprozin Revenue by Application (2017-2028)
8.3 Asia Pacific Oxaprozin Market Size by Region
8.3.1 Asia Pacific Oxaprozin Sales by Region (2017-2028)
8.3.2 Asia Pacific Oxaprozin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Oxaprozin Market Size by Type
9.1.1 Latin America Oxaprozin Sales by Type (2017-2028)
9.1.2 Latin America Oxaprozin Revenue by Type (2017-2028)
9.2 Latin America Oxaprozin Market Size by Application
9.2.1 Latin America Oxaprozin Sales by Application (2017-2028)
9.2.2 Latin America Oxaprozin Revenue by Application (2017-2028)
9.3 Latin America Oxaprozin Market Size by Country
9.3.1 Latin America Oxaprozin Sales by Country (2017-2028)
9.3.2 Latin America Oxaprozin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oxaprozin Market Size by Type
10.1.1 Middle East and Africa Oxaprozin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oxaprozin Revenue by Type (2017-2028)
10.2 Middle East and Africa Oxaprozin Market Size by Application
10.2.1 Middle East and Africa Oxaprozin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oxaprozin Revenue by Application (2017-2028)
10.3 Middle East and Africa Oxaprozin Market Size by Country
10.3.1 Middle East and Africa Oxaprozin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oxaprozin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Helsinn
11.2.1 Helsinn Corporation Information
11.2.2 Helsinn Overview
11.2.3 Helsinn Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Helsinn Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Helsinn Recent Developments
11.3 Taisho
11.3.1 Taisho Corporation Information
11.3.2 Taisho Overview
11.3.3 Taisho Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Taisho Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Taisho Recent Developments
11.4 Ildong
11.4.1 Ildong Corporation Information
11.4.2 Ildong Overview
11.4.3 Ildong Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ildong Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ildong Recent Developments
11.5 PD-Rx Pharmaceuticals
11.5.1 PD-Rx Pharmaceuticals Corporation Information
11.5.2 PD-Rx Pharmaceuticals Overview
11.5.3 PD-Rx Pharmaceuticals Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 PD-Rx Pharmaceuticals Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 PD-Rx Pharmaceuticals Recent Developments
11.6 Therapicon
11.6.1 Therapicon Corporation Information
11.6.2 Therapicon Overview
11.6.3 Therapicon Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Therapicon Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Therapicon Recent Developments
11.7 Neolpharma
11.7.1 Neolpharma Corporation Information
11.7.2 Neolpharma Overview
11.7.3 Neolpharma Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Neolpharma Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Neolpharma Recent Developments
11.8 Apotex Corporation
11.8.1 Apotex Corporation Corporation Information
11.8.2 Apotex Corporation Overview
11.8.3 Apotex Corporation Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Apotex Corporation Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Apotex Corporation Recent Developments
11.9 Yichang Dongyangguang Changjiang Pharmaceutical
11.9.1 Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
11.9.2 Yichang Dongyangguang Changjiang Pharmaceutical Overview
11.9.3 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments
11.10 Hubei Baike Hengdi Pharmaceutical
11.10.1 Hubei Baike Hengdi Pharmaceutical Corporation Information
11.10.2 Hubei Baike Hengdi Pharmaceutical Overview
11.10.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hubei Baike Hengdi Pharmaceutical Recent Developments
11.11 Fuan Pharmaceutical Group
11.11.1 Fuan Pharmaceutical Group Corporation Information
11.11.2 Fuan Pharmaceutical Group Overview
11.11.3 Fuan Pharmaceutical Group Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Fuan Pharmaceutical Group Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Fuan Pharmaceutical Group Recent Developments
11.12 Hubei Baike Hengdi Pharmaceutical
11.12.1 Hubei Baike Hengdi Pharmaceutical Corporation Information
11.12.2 Hubei Baike Hengdi Pharmaceutical Overview
11.12.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hubei Baike Hengdi Pharmaceutical Recent Developments
11.31 Pfizer
11.31.1 Pfizer Corporation Information
11.31.2 Pfizer Overview
11.31.3 Pfizer Oxaprozin Sales, Price, Revenue and Gross Margin (2017-2022)
11.31.4 Pfizer Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
11.31.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oxaprozin Industry Chain Analysis
12.2 Oxaprozin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oxaprozin Production Mode & Process
12.4 Oxaprozin Sales and Marketing
12.4.1 Oxaprozin Sales Channels
12.4.2 Oxaprozin Distributors
12.5 Oxaprozin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oxaprozin Industry Trends
13.2 Oxaprozin Market Drivers
13.3 Oxaprozin Market Challenges
13.4 Oxaprozin Market Restraints
14 Key Findings in The Global Oxaprozin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Oxaprozin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsule
Table 4. Global Oxaprozin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Oxaprozin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Oxaprozin Sales by Region (2017-2022) & (KG)
Table 7. Global Oxaprozin Sales Market Share by Region (2017-2022)
Table 8. Global Oxaprozin Sales by Region (2023-2028) & (KG)
Table 9. Global Oxaprozin Sales Market Share by Region (2023-2028)
Table 10. Global Oxaprozin Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Oxaprozin Revenue Market Share by Region (2017-2022)
Table 12. Global Oxaprozin Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Oxaprozin Revenue Market Share by Region (2023-2028)
Table 14. Global Oxaprozin Sales by Manufacturers (2017-2022) & (KG)
Table 15. Global Oxaprozin Sales Share by Manufacturers (2017-2022)
Table 16. Global Oxaprozin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Oxaprozin Revenue Share by Manufacturers (2017-2022)
Table 18. Oxaprozin Price by Manufacturers (2017-2022) &(US$/G)
Table 19. Global Oxaprozin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Oxaprozin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaprozin as of 2021)
Table 21. Oxaprozin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Oxaprozin Product Offered
Table 23. Date of Manufacturers Enter into Oxaprozin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oxaprozin Sales by Type (2017-2022) & (KG)
Table 26. Global Oxaprozin Sales by Type (2023-2028) & (KG)
Table 27. Global Oxaprozin Sales Share by Type (2017-2022)
Table 28. Global Oxaprozin Sales Share by Type (2023-2028)
Table 29. Global Oxaprozin Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Oxaprozin Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Oxaprozin Revenue Share by Type (2017-2022)
Table 32. Global Oxaprozin Revenue Share by Type (2023-2028)
Table 33. Oxaprozin Price by Type (2017-2022) & (US$/G)
Table 34. Global Oxaprozin Price Forecast by Type (2023-2028) & (US$/G)
Table 35. Global Oxaprozin Sales by Application (2017-2022) & (KG)
Table 36. Global Oxaprozin Sales by Application (2023-2028) & (KG)
Table 37. Global Oxaprozin Sales Share by Application (2017-2022)
Table 38. Global Oxaprozin Sales Share by Application (2023-2028)
Table 39. Global Oxaprozin Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Oxaprozin Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Oxaprozin Revenue Share by Application (2017-2022)
Table 42. Global Oxaprozin Revenue Share by Application (2023-2028)
Table 43. Oxaprozin Price by Application (2017-2022) & (US$/G)
Table 44. Global Oxaprozin Price Forecast by Application (2023-2028) & (US$/G)
Table 45. North America Oxaprozin Sales by Type (2017-2022) & (KG)
Table 46. North America Oxaprozin Sales by Type (2023-2028) & (KG)
Table 47. North America Oxaprozin Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Oxaprozin Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Oxaprozin Sales by Application (2017-2022) & (KG)
Table 50. North America Oxaprozin Sales by Application (2023-2028) & (KG)
Table 51. North America Oxaprozin Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Oxaprozin Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Oxaprozin Sales by Country (2017-2022) & (KG)
Table 54. North America Oxaprozin Sales by Country (2023-2028) & (KG)
Table 55. North America Oxaprozin Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Oxaprozin Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Oxaprozin Sales by Type (2017-2022) & (KG)
Table 58. Europe Oxaprozin Sales by Type (2023-2028) & (KG)
Table 59. Europe Oxaprozin Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Oxaprozin Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Oxaprozin Sales by Application (2017-2022) & (KG)
Table 62. Europe Oxaprozin Sales by Application (2023-2028) & (KG)
Table 63. Europe Oxaprozin Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Oxaprozin Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Oxaprozin Sales by Country (2017-2022) & (KG)
Table 66. Europe Oxaprozin Sales by Country (2023-2028) & (KG)
Table 67. Europe Oxaprozin Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Oxaprozin Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Oxaprozin Sales by Type (2017-2022) & (KG)
Table 70. Asia Pacific Oxaprozin Sales by Type (2023-2028) & (KG)
Table 71. Asia Pacific Oxaprozin Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Oxaprozin Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Oxaprozin Sales by Application (2017-2022) & (KG)
Table 74. Asia Pacific Oxaprozin Sales by Application (2023-2028) & (KG)
Table 75. Asia Pacific Oxaprozin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Oxaprozin Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Oxaprozin Sales by Region (2017-2022) & (KG)
Table 78. Asia Pacific Oxaprozin Sales by Region (2023-2028) & (KG)
Table 79. Asia Pacific Oxaprozin Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Oxaprozin Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Oxaprozin Sales by Type (2017-2022) & (KG)
Table 82. Latin America Oxaprozin Sales by Type (2023-2028) & (KG)
Table 83. Latin America Oxaprozin Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Oxaprozin Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Oxaprozin Sales by Application (2017-2022) & (KG)
Table 86. Latin America Oxaprozin Sales by Application (2023-2028) & (KG)
Table 87. Latin America Oxaprozin Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Oxaprozin Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Oxaprozin Sales by Country (2017-2022) & (KG)
Table 90. Latin America Oxaprozin Sales by Country (2023-2028) & (KG)
Table 91. Latin America Oxaprozin Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Oxaprozin Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Oxaprozin Sales by Type (2017-2022) & (KG)
Table 94. Middle East and Africa Oxaprozin Sales by Type (2023-2028) & (KG)
Table 95. Middle East and Africa Oxaprozin Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Oxaprozin Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Oxaprozin Sales by Application (2017-2022) & (KG)
Table 98. Middle East and Africa Oxaprozin Sales by Application (2023-2028) & (KG)
Table 99. Middle East and Africa Oxaprozin Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Oxaprozin Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Oxaprozin Sales by Country (2017-2022) & (KG)
Table 102. Middle East and Africa Oxaprozin Sales by Country (2023-2028) & (KG)
Table 103. Middle East and Africa Oxaprozin Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Oxaprozin Revenue by Country (2023-2028) & (US$ Million)
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Major Businesses
Table 107. Pfizer Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 108. Pfizer Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Pfizer Recent Developments
Table 110. Helsinn Corporation Information
Table 111. Helsinn Description and Major Businesses
Table 112. Helsinn Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 113. Helsinn Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Helsinn Recent Developments
Table 115. Taisho Corporation Information
Table 116. Taisho Description and Major Businesses
Table 117. Taisho Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 118. Taisho Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Taisho Recent Developments
Table 120. Ildong Corporation Information
Table 121. Ildong Description and Major Businesses
Table 122. Ildong Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 123. Ildong Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Ildong Recent Developments
Table 125. PD-Rx Pharmaceuticals Corporation Information
Table 126. PD-Rx Pharmaceuticals Description and Major Businesses
Table 127. PD-Rx Pharmaceuticals Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 128. PD-Rx Pharmaceuticals Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. PD-Rx Pharmaceuticals Recent Developments
Table 130. Therapicon Corporation Information
Table 131. Therapicon Description and Major Businesses
Table 132. Therapicon Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 133. Therapicon Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Therapicon Recent Developments
Table 135. Neolpharma Corporation Information
Table 136. Neolpharma Description and Major Businesses
Table 137. Neolpharma Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 138. Neolpharma Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Neolpharma Recent Developments
Table 140. Apotex Corporation Corporation Information
Table 141. Apotex Corporation Description and Major Businesses
Table 142. Apotex Corporation Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 143. Apotex Corporation Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Apotex Corporation Recent Developments
Table 145. Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
Table 146. Yichang Dongyangguang Changjiang Pharmaceutical Description and Major Businesses
Table 147. Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 148. Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Yichang Dongyangguang Changjiang Pharmaceutical Recent Developments
Table 150. Hubei Baike Hengdi Pharmaceutical Corporation Information
Table 151. Hubei Baike Hengdi Pharmaceutical Description and Major Businesses
Table 152. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 153. Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Hubei Baike Hengdi Pharmaceutical Recent Developments
Table 155. Fuan Pharmaceutical Group Corporation Information
Table 156. Fuan Pharmaceutical Group Description and Major Businesses
Table 157. Fuan Pharmaceutical Group Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 158. Fuan Pharmaceutical Group Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Fuan Pharmaceutical Group Recent Developments
Table 160. Hubei Baike Hengdi Pharmaceutical Corporation Information
Table 161. Hubei Baike Hengdi Pharmaceutical Description and Major Businesses
Table 162. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 163. Hubei Baike Hengdi Pharmaceutical Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Hubei Baike Hengdi Pharmaceutical Recent Developments
Table 165. Pfizer Corporation Information
Table 166. Pfizer Description and Major Businesses
Table 167. Pfizer Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
Table 168. Pfizer Oxaprozin Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Pfizer Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Oxaprozin Distributors List
Table 173. Oxaprozin Customers List
Table 174. Oxaprozin Market Trends
Table 175. Oxaprozin Market Drivers
Table 176. Oxaprozin Market Challenges
Table 177. Oxaprozin Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxaprozin Product Picture
Figure 3. Global Oxaprozin Market Share by Type in 2021 & 2028
Figure 3. Tablets Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Oxaprozin Market Share by Application in 2021 & 2028
Figure 6. Rheumatoid Arthritis
Figure 7. Chronic Infectious Arthritis
Figure 8. Osteoarthritis
Figure 9. Ankylosing Spondylitis
Figure 10. Neck Shoulder Wrist Syndrome
Figure 11. Periarthritis Of Shoulder
Figure 12. Gout
Figure 13. Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
Figure 14. Other
Figure 15. Oxaprozin Report Years Considered
Figure 16. Global Oxaprozin Sales 2017-2028 (KG)
Figure 17. Global Oxaprozin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Oxaprozin Revenue 2017-2028 (US$ Million)
Figure 19. Global Oxaprozin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Oxaprozin Sales Market Share by Region (2017-2022)
Figure 21. Global Oxaprozin Sales Market Share by Region (2023-2028)
Figure 22. North America Oxaprozin Sales YoY (2017-2028) & (KG)
Figure 23. North America Oxaprozin Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Oxaprozin Sales YoY (2017-2028) & (KG)
Figure 25. Europe Oxaprozin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Oxaprozin Sales YoY (2017-2028) & (KG)
Figure 27. Asia-Pacific Oxaprozin Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Oxaprozin Sales YoY (2017-2028) & (KG)
Figure 29. Latin America Oxaprozin Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Oxaprozin Sales YoY (2017-2028) & (KG)
Figure 31. Middle East & Africa Oxaprozin Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Oxaprozin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Oxaprozin in the World: Market Share by Oxaprozin Revenue in 2021
Figure 34. Global Oxaprozin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Oxaprozin Sales Market Share by Type (2017-2028)
Figure 36. Global Oxaprozin Revenue Market Share by Type (2017-2028)
Figure 37. Global Oxaprozin Sales Market Share by Application (2017-2028)
Figure 38. Global Oxaprozin Revenue Market Share by Application (2017-2028)
Figure 39. North America Oxaprozin Sales Market Share by Type (2017-2028)
Figure 40. North America Oxaprozin Revenue Market Share by Type (2017-2028)
Figure 41. North America Oxaprozin Sales Market Share by Application (2017-2028)
Figure 42. North America Oxaprozin Revenue Market Share by Application (2017-2028)
Figure 43. North America Oxaprozin Sales Share by Country (2017-2028)
Figure 44. North America Oxaprozin Revenue Share by Country (2017-2028)
Figure 45. U.S. Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Oxaprozin Sales Market Share by Type (2017-2028)
Figure 48. Europe Oxaprozin Revenue Market Share by Type (2017-2028)
Figure 49. Europe Oxaprozin Sales Market Share by Application (2017-2028)
Figure 50. Europe Oxaprozin Revenue Market Share by Application (2017-2028)
Figure 51. Europe Oxaprozin Sales Share by Country (2017-2028)
Figure 52. Europe Oxaprozin Revenue Share by Country (2017-2028)
Figure 53. Germany Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 54. France Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Oxaprozin Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Oxaprozin Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Oxaprozin Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Oxaprozin Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Oxaprozin Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Oxaprozin Revenue Share by Region (2017-2028)
Figure 64. China Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 67. India Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 69. Taiwan Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 73. Philippines Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Oxaprozin Sales Market Share by Type (2017-2028)
Figure 75. Latin America Oxaprozin Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Oxaprozin Sales Market Share by Application (2017-2028)
Figure 77. Latin America Oxaprozin Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Oxaprozin Sales Share by Country (2017-2028)
Figure 79. Latin America Oxaprozin Revenue Share by Country (2017-2028)
Figure 80. Mexico Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Oxaprozin Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Oxaprozin Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Oxaprozin Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Oxaprozin Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Oxaprozin Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Oxaprozin Revenue Share by Country (2017-2028)
Figure 89. Turkey Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Oxaprozin Revenue (2017-2028) & (US$ Million)
Figure 92. Oxaprozin Value Chain
Figure 93. Oxaprozin Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
Industry Market Size
